Mitral robotics: 3% SAM and the predictive value of C-sept distance

The challenge of SAM in robotic mitral surgery

Systolic anterior motion (SAM) is a known complication of mitral valve repair, characterized by a displacement of the anterior leaflet toward the left ventricular outflow tract (LVOT) during the systolic phase. This phenomenon induces mitral regurgitation and dynamic obstruction of the aortic flow. While anatomical risk factors are well documented in conventional surgery, their clinical relevance within the specific context of robot-assisted mitral valve repair (RAMVR) had not yet been formally established.

The objective of this study was to evaluate the incidence of SAM after RAMVR and to analyze the predictive value of traditional risk factors for this minimally invasive approach. Researchers reviewed the perioperative parameters of 197 consecutive patients who underwent isolated RAMVR to identify the truly determining echocardiographic and surgical variables.

The main hypothesis tested was based on the stratification of patients into two groups according to their preoperative risk profile: a low-risk group (score 0 to 4) and a high-risk group (score 5 to 9), based on the accumulation of classic risk factors. The study also sought to determine whether specific surgical strategies, such as the use of flexible annuloplasty rings, could constitute a viable preventive approach in the face of high-risk anatomy.

Methodology: Retrospective analysis of 197 RAMVR procedures

This retrospective clinical study analyzed the perioperative parameters of 197 consecutive patients who underwent isolated robot-assisted mitral valve repair (RAMVR). The objective was to evaluate the relevance of classic risk factors for systolic anterior motion (SAM) within the specific context of robotic surgery.

The protocol structured the analysis around the following axes:

• Patient stratification: The cohort was divided into two groups based on the total number of pre-existing risk factors identified in the literature: the low-risk group (score of 0 to 4) and the high-risk group (score of 5 to 9).
• Echocardiographic evaluation: Systematic pre-operative measurements were performed, including the anterior mitral leaflet (AML) length and the distance between the coaptation point and the interventricular septum (C-sept distance).
• Surgical technique: The use of flexible annuloplasty bands has been documented as a potential preventive strategy, representing 98.6% of cases in the high-risk group versus 91.1% in the low-risk group (p = 0.034).
• Statistical analysis: The predictive value of risk factors was evaluated by univariate analysis. A ROC (Receiver Operating Characteristic) curve analysis was conducted to determine the discriminant capacity of AML length and C-sept distance regarding the occurrence of SAM.

Results: Incidence and predictors of SAM in robotic surgery

The retrospective analysis of 197 robot-assisted mitral valve repair (RAMVR) procedures reveals an overall incidence of systolic anterior motion (SAM) of 3.0%, representing 6 cases across the entire cohort. The study shows no statistically significant difference in the occurrence of SAM between patients stratified as low-risk and those at high-risk.

Analysis of predictive and ultrasound factors

Univariate analysis identifies the distance between the coaptation zone and the interventricular septum (C-sept distance) as the sole significant predictor of SAM. ROC (Receiver Operating Characteristic) curve analysis confirms the discriminant value of two preoperative ultrasound parameters:

• The C-sept distance.
• The length of the anterior mitral leaflet (AML).

Surgical strategies and clinical evolution

A notable difference was observed in the surgical technique: surgeons more frequently used flexible annuloplasty rings in the high-risk group (98.6% vs. 91.1%, p = 0.034), suggesting a preventive strategic adaptation.

Clinically, the majority of identified SAM episodes were stabilized through intraoperative medical management and did not persist during the postoperative phase. Overall clinical outcomes remain comparable between the two risk groups, validating the safety of the robotic approach even in patients presenting with classic anatomical risk factors.

Controlled SAM incidence in robotics

The results of this retrospective study involving 197 patients demonstrate that the incidence of systolic anterior motion (SAM) after robotic-assisted mitral valve repair (RAMVR) remains low (3.0%). This figure is particularly interesting as it does not differ significantly between patients stratified as low-risk or high-risk (2.4% vs 4.1%, p = 0.79). For the cardiac surgeon, this suggests that the robotic approach, combined with specific technical choices, allows for the neutralization of certain traditional risk factors.

The analysis identifies two major preoperative ultrasound predictors: the anterior leaflet length and the C-sept distance (coaptation-septum). Furthermore, the C-sept distance proved to be the only significant univariate predictor. Clinically, these measurements provide the practitioner with a more reliable predictive window than global risk scores for anticipating left ventricular outflow tract (LVOT) obstruction.

Technical limits and protective choices

The study presents inherent limitations due to its retrospective design and the low number of SAM events (n=6), which may limit statistical power. Nevertheless, a strong point emerges: the predominant use of flexible annuloplasty bands in the high-risk group (98.6% versus 91.1% in the low-risk group, p = 0.034). This preventive surgical strategy seems to have played a decisive role in the absence of major post-operative complications, as SAM was managed medically in the majority of cases without long-term persistence.

Summary of results

This study of 197 robotic mitral valve repairs (RAMVR) reports a SAM incidence of only 3.0%, with no significant difference between low- and high-risk groups (2.4% vs 4.1%). Coaptation-septum distance (C-sept) and anterior leaflet length are the only discriminant echocardiographic predictors identified by ROC analysis.

In concrete terms, for the practitioner:

• Reliabilize your screening: Do not rely solely on classic risk scores; it is imperative to measure the C-sept distance and the length of the anterior leaflet preoperatively to anticipate LVOT obstruction.
• Opt for flexibility: The use of flexible annuloplasty rings appears to neutralize the excess risk in anatomically predisposed patients, constituting an effective preventive strategy.
• Medical caution before reintervention: Most cases of SAM after RAMVR are resolved through simple hemodynamic and medical management, without the need for immediate surgical reintervention.

Technical Lexicon of the Study

SAM (Systolic Anterior Motion): Systolic displacement of the anterior leaflet of the mitral valve toward the left ventricular outflow tract (LVOT), leading to dynamic obstruction and mitral regurgitation.

LVOT (Left Ventricle Outflow Tract): Left ventricle outflow segment located below the aortic valve, whose obstruction by the mitral leaflet defines the clinical severity of SAM.

RAMVR (Robotically Assisted Mitral Valve Repair): Mitral valve repair technique performed via robotic assistance, allowing a minimally invasive approach for the treatment of degenerative pathologies.

C-sept distance: Echocardiographic parameter measuring the distance between the coaptation point of the mitral leaflets and the interventricular septum; a key predictive factor for post-operative obstruction.

Flexible annuloplasty bands: Mitral ring reconstruction prostheses designed to stabilize the repair while preserving the physiological dynamics of the ring during the cardiac cycle.

ROC (Receiver Operating Characteristic) Analysis: Statistical tool used in the study to evaluate the discriminatory performance of anterior leaflet length and C-sept distance in predicting SAM.

Information intended for healthcare professionals. This content may contain errors or truncated summaries. We recommend always verifying with the original source article. Delynov disclaims any responsibility regarding the use of this information. This document is not intended for patients or the general public.